Artificial Intelligence in New Cardiac MR Markers for Congenital Heart Disease

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Jul 31, 2023

Keywords

ClinConnect Summary

Background:

An increasing number of children with complex congenital heart disease (CHD) are today treated and survive into adulthood. They are in need of a lifelong surveillance for cardiovascular complications and an individualised treatment.

In paediatric aortic and pulmonary valve disease, the long-term complications are related to valvular dysfunction with myocardial fibrosis and ventricular dysfunction as a result of longstanding volume or pressure overload. Many patients will need surgery or interventional treatment already in childhood, where the optimal timing of the intervention...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • aortic valve disease
• • or pulmonary valve disease
• • clinical indication for valvular surgery
• • or clinical indication for valvular intervention
• Exclusion Criteria:
• • contraindications for MRI
• • need of sedation or general anesthesia, unless there is a clinical indication for a CMR